Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares GlobeNewswire August 01, 2025 CAMBRIDGE, Mass., Aug. 01, 2025 (GLOBE NEWSWIRE) — Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced the closing of […]

Taitron Announces Quarterly Cash Dividend GlobeNewswire August 01, 2025 LOS ANGELES, Aug. 01, 2025 (GLOBE NEWSWIRE) — Taitron Components Incorporated (NASDAQ:TAIT) today announced that its Board of Directors has declared a quarterly cash dividend of $0.035 per share of common stock, payable on August 29, 2025 to stockholders of record as of the close of

Shore Bancshares, Inc. (NASDAQ -SHBI) announced that the Board of Directors has declared a quarterly common stock dividend in the amount of $0.12 per share, payable August 25, 2025 to stockholders of record on August 11, 2025. https://mma.prnewswire.com/media/803952/Shore_Bancshares_Logo.jpg Shore Bancshares Information Shore Bancshares is a financial holding company headquartered in Easton, Maryland and is the

(NASDAQ:SRPT), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ: SRPT) and certain of its officers. Class Definition This lawsuit seeks to recover damages

(NYSE:FI), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fiserv, Inc. (“Fiserv” or “the Company”) (NYSE: FI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action

FI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fiserv, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit

(NasdaqGM:RCKT), Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 01, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Rocket Pharmaceuticals, Inc. (“Rocket Pharmaceuticals” or the “Company”) (NASDAQ: RCKT) investors of a class action representing investors that bought securities between February 27, 2025 and

Rocket Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 11, 2025 Deadline to file Lead Plaintiff Motion. GlobeNewswire August 01, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 01, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm

(NasdaqGM:TVGN),(NASDAQ:TVGNW), WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Tevogen.AI. Our mission remains steadfast: delivering clinically impactful, economically accessible therapies